First Advantage to Release Second Quarter 2024 Financial Results and Hold Investor Conference Call on August 8, 2024
July 18, 2024 07:02 ET
|
First Advantage Corporation
ATLANTA, July 18, 2024 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of employment background screening, identity, and verification solutions, will issue its...
LuxUrban Hotels Announces Full Exercise of Over Allotment Option
July 18, 2024 07:01 ET
|
LuxUrban Hotels
MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- LuxUrban Hotels Inc. (“LuxUrban” or the “Company”) (Nasdaq: LUXH), which secures long-term operating rights for entire hotels through Master Lease Agreements...
Virtu Announces Second Quarter 2024 Results
July 18, 2024 07:00 ET
|
Virtu Financial, LLC
NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NASDAQ: VIRT), a leading provider of financial services and products that leverages cutting edge technology to deliver innovative,...
Universal Stainless Reaches New Five-Year Labor Agreement at its North Jackson Facility
July 18, 2024 07:00 ET
|
Universal Stainless & Alloy Products, Inc.
BRIDGEVILLE, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Universal Stainless & Alloy Products, Inc. (Nasdaq: USAP) reported today that it has reached a new five-year collective bargaining agreement...
Digital media pioneers join Lee Enterprises board
July 18, 2024 07:00 ET
|
Lee Enterprises Inc.
DAVENPORT, Iowa, July 18, 2024 (GLOBE NEWSWIRE) -- Madeline McIntosh and Jon Miller, pioneering media executives with extensive accomplishments in digital technology, consumer marketing and business...
Vigil Neuroscience Provides Update on Clinical Development Strategy to Pursue Potential Accelerated Approval Pathway for Iluzanebart in ALSP
July 18, 2024 07:00 ET
|
Vigil Neuroscience, Inc.
WATERTOWN, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment...
Apellis Pharmaceuticals to Host Conference Call on August 1, 2024, to Discuss Second Quarter 2024 Financial Results
July 18, 2024 07:00 ET
|
Apellis Pharmaceuticals, Inc.
WALTHAM, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference call and webcast to discuss its second quarter...
Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024
July 18, 2024 07:00 ET
|
Agios Pharmaceuticals, Inc.
CAMBRIDGE, Mass., July 18, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today...
Wasabi Technologies Now Available in Climb Channel Solutions’ Portfolio of GSA Offerings
July 18, 2024 07:00 ET
|
Climb Channel Solutions
EATONTOWN, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ:...
ECARX to Report Second Quarter 2024 Financial Results on August 8, 2024
July 18, 2024 07:00 ET
|
ECARX LIMITED
SHANGHAI, July 18, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings, Inc. (Nasdaq: ECX) ("ECARX"), a global mobility tech provider, today announced that it will report its financial results for the second...